Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors

Atherosclerosis

Volumn 177, Issue 2, 2004, Pages 375-381

  Shai, Iris ^a,f   Stampfer, Meir J ^a,b   Ma, Jing ^a,b   Manson, JoAnn E ^a,b,c   Hankinson, Susan E ^a,b   Cannuscio, Carolyn ^d   Selhub, Jacob ^e   Curhan, Gary ^b   Rimm, Eric B ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CHANNING LABORATORY   (United States)

^c Brigham Women Hosp Harvard Med S

^d MERCK RESEARCH LABORATORIES   (United States)

^e TUFTS UNIVERSITY   (United States)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Biomarkers; Homocysteine; Postmenopausal

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPID; RIBOFLAVIN; THIAMINE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; FAMILY HISTORY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; IN VITRO STUDY; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING;

C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; THIAMINE;

EID: 8644235875     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.07.020     Document Type: Article

References (43)

1. The Homocysteine Studies Collabration Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis JAMA 288 2002 2015 2022
2. D.S. Wald, M. Law, and J.K. Morris Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis BMJ 325 2002 1202 1209
3. A. Tawakol, M.A. Forgione, and M. Stuehlinger Homocysteine impairs coronary microvascular dilator function in humans J Am Coll Cardiol 40 2002 1051 1081
4. L. Tang, Mamotte CDS, and F.M. Van Bockxmeer The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle Atherosclerosis 136 1998 169 173
5. G.M. Rodgers, and W.H. Kane Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator J Clin Invest 77 1986 1909 1916
6. J.C. Tsai, M.A. Perrella, and M. Yoshizumi Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis Proc Natl Acad Sci USA 91 1994 6369 6373
7. K.S. McCully, and M.P. Vezeridis Histopathological effects of homocysteine thiolactone on epithelial and stromal tissues Exp Mol Pathol 51 1989 159 170
8. J. Roth, M. Goebeler, and S. Ludwig Homocysteine inhibits tumor necrosis factor-induced activation of endothelium via modulation of nuclear factor-kappa b activity Biochim Biophys Acta 1540 2001 154 165
9. B.E. Van Aken, J. Jansen, and S.J. van Deventer Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells Blood Coagul Fibrinolysis 11 2000 159 164
10. M.D. Silverman, R.J. Tumuluri, and M. Davis Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion Arterioscler Thromb Vasc Biol 22 2002 587 592
11. M.A. Hofmann, E. Lalla, and Lu Yan Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model J Clin Invest 107 2001 675 683
12. Janssen-Heininger Y.M.W., M.E. Poynter, and P.A. Baeuerle Recent advances towards understanding redox mechanisms in the activation of nuclear factor B Free Rad Biol Med 28 2000 1317 1327
13. D. Rothenbacher, H.G. Fischer, and A. Hoffmeister Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters Atherosclerosis 162 2002 193 200
14. B. Bayes, M.C. Pastor, and J. Bonal Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients Nephrol Dial Transplant 18 2003 106 112
15. K. Nilsson, B. Hultberg, and L. Gustafson Lack of association between plasma homocysteine and inflammation in psychogeriatric patients Dement Geriatr Cogn Disord 14 2002 151 155
16. O.A. Mojiminiyi, N. Abdella, and M.A. Moussa Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus Diabetes Res Clin Pract 58 2002 37 44
17. G. Rose, and H. Blackburn Cardiovascular survey methods 2nd ed. 1982 World Health Organization Geneva
18. M.J. Stampfer, W.C. Willett, and F.E. Speizer Test of the national death index Am J Epidemiol 119 1984 837 839
19. W.C. Willett, L. Sampson, and M.J. Stampfer Reproducibility and validity of a semi quantitative food frequency questionnaire Am J Epidemiol 122 1985 51 65
20. US Department of Agriculture. Composition of Foods-Raw, Processed, and Prepared, 1963-1992. Agricultural Handbook Series No. 8. Washington, DC: US Dept of Agriculture; 1993.
21. K. Wu, K.J. Helzlsouer, and G.W. Comstock A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer Cancer Epidemiol Biomarkers Prev 8 1999 209 217
22. J. Chen, E. Giovannucci, and K. Kelsey A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer Cancer Res 56 1996 4862 4864
23. C.C. Allain, L.S. Poon, and C.S.G. Chan Enzymatic determination of total serum cholesterol Clin Chem 20 1974 470 475
24. W.C. Willett, and M.J. Stampfer Total energy intake: implications for epidemiologic analyses Am J Epidemiol 124 1986 17 27
25. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36
26. P.M. Ridker, C.H. Hennekens, and J.E. Buring C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
27. K.R. Dimitrova, K. DeGroot, and A.K. Myers Estrogen and homocysteine Cardiovasc Res 53 2002 577 588
28. J.K. Pai, G.C. Curhan, and C.C. Cannuscio Stability of novel plasma markers associated with cardiovascular disease: processing within 36 h of specimen collection Clin Chem 48 2002 1781 1784
29. J. Selhub, P.F. Jacques, and P.W. Wilson Vitamin status and intake as primary determinants of homocysteinemia in an elderly population JAMA 270 1993 2693 2698
30. E. Rossi, J.P. Beilby, and B.M. McQuillan Biological variability and reference intervals for total plasma homocysteine Ann Clin Biochem 36 1999 56 61
31. E.M. Macy, T.E. Hayes, and R.P. Tracy Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications Clin Chem 43 1997 52 58
32. D. Aderka The potential biological and clinical significance of the soluble tumor necrosis factor receptors Cytokine Growth Factor Rev 7 1996 231 240
33. P. Kanani, C. Sinkey, and R. Browning Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans Circulation 100 1999 1161 1168
34. L. Lind Circulating markers of inflammation and atherosclerosis Atherosclerosis 169 2 2003 203 214
35. J.K. Pai, J. Ma, and S.E. Hankinson Are C-reactive protein (CRP) and fibrinogen associated with increased risk of MI in traditionally low-Risk women? Abstract 26 Circulation 107 2003 7001
36. M. Klerk, P. Verhoef, R. Clarke MTHFR Studies Collaboration Group MTHFR 677CT polymorphism and risk of coronary heart disease: a meta-analysis JAMA 288 2002 2023 2031
37. A. De Bree, W.M. Verschuren, and D. Kromhout Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease Pharmacol Rev 54 2002 599 618
38. E.B. Rimm, W.C. Willett, and F.B. Hu Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women JAMA 279 1998 359 364
39. G. Schnyder, M. Roffi, and Y. Flammer Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial JAMA 288 2002 973 979
40. D.G. Hackam, and S.S. Anand Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence JAMA 290 7 2003 932 940
41. P. Verhoef, W.J. Pasman, and T. Van Vliet Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans Am J Clin Nutr 76 6 2002 1244 1248
42. C.H. Halsted, J.A. Villanueva, and A.M. Devlin Metabolic interactions of alcohol and folate J Nutr 132 Suppl 8 2002 2367S 2372S
43. E.B. Rimm, P. Williams, and K. Fosher Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors BMJ 319 7224 1999 1523 1528